Drug Profile
Research programme: selective androgen receptor modulators - Orion
Alternative Names: Arcarine; ORM-11984Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Orion
- Class
- Mechanism of Action Selective androgen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Andropause; Benign prostatic hyperplasia; Hypogonadism; Osteoporosis; Prostate cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Andropause in Finland (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Benign-prostatic-hyperplasia in Finland (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Hypogonadism in Finland (PO)